Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value Per Share
-
Shares outstanding
-
107,800,271
-
Total 13F shares
-
27,893,149
-
Share change
-
-2,658,755
-
Total reported value
-
$424,898,393
-
Put/Call ratio
-
95%
-
Price per share
-
$15.24
-
Number of holders
-
127
-
Value change
-
-$109,128,726
-
Number of buys
-
62
-
Number of sells
-
68
Institutional Holders of Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) as of Q3 2016
As of 30 Sep 2016 Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) had 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,893,149 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, TimesSquare Capital Management, LLC, BB BIOTECH AG, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, Hillhouse Capital Management, Ltd., BlackRock Institutional Trust Company, N.A., STATE STREET CORP, and WASATCH ADVISORS INC.
This table shows 127 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.